Fed. Circ. Clarifies But Won't Redo AIA On-Sale Bar Ruling
The Federal Circuit on Tuesday said it won't reconsider invalidating four Helsinn Healthcare SA nausea drug patents in a ruling over the scope of the America Invents Act's on-sale bar, but...To view the full article, register now.
Already a subscriber? Click here to view full article